Search
Media & Resources
New private health exchanges offer large companies cost control. (Steve Raetzman of Mercer)
While offerings lag, backlog of U.S. deals is sizable; Facebook could trigger rebound.
Even if measure becomes law, corporate end users of derivatives could face higher costs. (Michael Bopp of Gibson Dunn & Crutcher)
Even if measure becomes law, corporate end users of derivatives could face higher costs. (Michael Bopp of Gibson Dunn & Crutcher)
Low borrowing costs elicit $430 bln of corporate issuance.
Biggest U.S. plans see funding shortfall swell 41%; pension-related charges hit $38.3 bln.